1362509-93-0

Idarucizumab

Product Code: 1682987

Product Name: Idarucizumab

Cas Number: 1362509-93-0

Order [ 1362509-93-0 ] Now

Maybe you are interested:

ENDO-N,N-DIMETHYL-BICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXAMIDE

2-(benzylcarbamimidoyl)-1-hydroxy-1-oxodiazanium

CAS RN 1362509-93-0 wholesale

1H-Pyrazole, 3,5-diphenyl-, compd. with 2,4,6-trinitrophenol

Propanamide,N-(1,4-dihydro-6,7-dimethyl-4-oxo-2-pteridinyl)-2,2-dimethyl-

CASNo 1362509-93-0 distributor

[1,2,4]Triazolo[1,5-a]pyridine-5-carboxamide,2-[[(ethylamino)carbonyl]amino]-N-methyl-7-(3-pyridinyl)-N-[1-(4-pyridinyl)ethyl]-

CAS Number 1362509-93-0 safety

1-(1-phenylpropan-2-yl)urea

[1,2,4]Triazolo[1,5-a]pyridine-5-carboxamide,2-[[(ethylamino)carbonyl]amino]-N-methyl-7-(3-pyridinyl)-N-[1-(2-pyridinyl)ethyl]-

Ethanone, 1-(4-nitro-1-naphthalenyl)-

ETHYL (4-NITROPHENYLAMINO) OXOACETATE

3-bromo-6-nitro-2H-chromen-2-one

CAS No 1362509-93-0 supplier

2-Amino-6-bromo-5-methoxybenzoic acid

Benzamide, 4-amino-N-(3-aminopropyl)-

Propanediimidoyl dichloride, 2,2-dichloro-N,N'-bis(2-methylphenyl)-

methyl n,n'-diphenylcarbamimidothioate

Benzenemethanamine,2-[[(2R,6S)-2,6-bis(3-methyl-2-pyridinyl)-1-piperidinyl]methyl]-, rel-

4-Cinnolinecarboxamide,N-[(3-chlorophenyl)methyl]-N-(cyclopropylmethyl)-3,4-dihydro-

Imidazo[5,1-a]isoquinoline-1-carboxamide,5,6-dihydro-8,9-dimethoxy-3-methyl-N-[2-(4-pyridinyl)ethyl]-,monohydrochloride

Furo[2,3-d]pyrimidin-4-amine, N-(2-methylpropyl)-5,6-diphenyl-

Phosphinecarboxylic acid, bis(1-methylethoxy)-, ethyl ester, oxide

22950-60-3

1-(4-bromophenyl)-3-(dibutylamino)propan-1-one

[1,2,4]Triazolo[1,5-a]pyridine-5-carboxamide,7-(2,3-dihydro-5-benzofuranyl)-N-ethyl-2-[[(ethylamino)carbonyl]amino]-

Pentanoic acid, 3-(acetyloxy)-5-chloro-5-oxo-, ethyl ester, (3S)-

(E)-1-(4-ethoxy-2-hydroxy-5-(morpholinomethyl)phenyl)-3-(pyridin-3-yl)prop-2-en-1-one

Carbamic acid, (1-formyl-2-methylpropyl)-, 2-methylpropyl ester, (R)-

?-Methyl-2-piperidinemethanol

54160-32-6

1-Propanone, 1-phenyl-2-(7H-pyrrolo[2,3-b]pyridin-7-yl)-,monohydrobromide

2-(2-ALLYLPHENOXY)ACETOHYDRAZIDE

[1,2,4]Triazolo[1,5-a]pyridine-5-carboxamide,7-(2-cyanophenyl)-N-ethyl-2-[[(ethylamino)carbonyl]amino]-

CAS # 1362509-93-0 manufacturer

L-Leucine,N-[N-[N-[N-[N-[N-[N-(N-L-alanyl-L-leucyl)-L-phenylalanyl]-L-phenylalanyl]-L-phenylalanyl]-L-a-aspartyl]-L-isoleucyl]-L-a-aspartyl]-

[1,2,4]Triazolo[1,5-a]pyridine-5-carboxamide,7-(3-chlorophenyl)-N-ethyl-2-[[(ethylamino)carbonyl]amino]-

Oxiranepropanoic acid, 2-tetradecyl-, methyl ester

1362509-93-0 msds

3-[(7e)-3-hydroxy-7-hydroxyimino-3a,6-dimethyl-1,2,3,4,5,5a,8,9,9a,9b-decahydrocyclopenta[a]naphthalen-6-yl]propanoic Acid

ethyl 2,3-diphenylpropanoate

Benzamide,N,N-diethyl-4-[phenyl(8-propyl-8-azabicyclo[3.2.1]oct-3-ylidene)methyl]-

2-methyl-n-[1-[4-methyl-5-[2-[(4-methyl-1,3-thiazol-2-yl)amino]-2-oxoethyl]sulfanyl-1,2,4-triazol-3-yl]ethyl]benzamide

Propanenitrile,3-[decyl[4-[(5,6-dibromo-2-benzothiazolyl)azo]phenyl]amino]-

2024-11-06 Idarucizumab,CAS No.1362509-93-0,Formula:. Find Related Products for Bulk Production or Scientific Research